Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript
Operator: Hello, everyone, and welcome to Cognition Therapeutics Fourth Quarter 2023 Earnings Call. Please note that this call is being recorded.
Cognition Therapeutics Inc (CGTX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 1,897,273 | $3,453,037 | -7% | 1.03% |
| 2. | Alyeska Investment Group Anand Parekh | 500,000 | $910,000 | 0% | |
| 3. | Timelo Investment Management Jean-Francois Tardif | 480,681 | $874,839 | 0.33% | |
| 4. | Corsair Capital Management Jay Petschek And Steven Major | 285,000 | $518,700 | 0.14% | |
| 5. | Carlson Capital Clint Carlson | 213,995 | $389,471 | -11% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.75 | 5,700 | Officer, Director | 291,345 | 2024-03-14 | Filing | |
| $2.66 | 10,000 | Director | 10,000 | 2022-11-29 | Filing | |
| $2.65 | 1,871 | Large Shareholder, Director | 309,748 | 2022-11-28 | Filing | |
| $2.65 | 12,220 | Large Shareholder, Director | 2,021,906 | 2022-11-28 | Filing | |
| $2.65 | 1,973 | Large Shareholder, Director | 326,733 | 2022-11-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.00 | 90 | Large Shareholder | 385,248 | 2021-10-13 | Filing | |
| $12.00 | 90 | Director | 385,248 | 2021-10-13 | Filing | |
| $12.00 | 33 | Large Shareholder | 2,177,985 | 2021-10-13 | Filing | |
| $12.00 | 74 | Large Shareholder | 2,210,377 | 2021-10-13 | Filing | |
| $12.00 | 12 | Director | 404,439 | 2021-10-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,205,377 | $4,079,947 | 0.02% | |
| 2. | 721,554 | $1,334,875 | 0% | |
| 3. | 508,719 | $941,130 | 0.5% | |
| 4. | 219,434 | $405,953 | 0% | |
| 5. | 174,798 | $323,454 | 0% |
News See All
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen and welcome to Cognition Therapeutics Second Quarter 2023 Earnings Conference Call. My name is Jenny and I will be your conference operator today.
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2022 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Cognition Therapeutics Incorporated Fourth Quarter and Fiscal Year 2022 Earnings Conference Call.
Hedge Fund and Insider Trading News: Carl Icahn, TCI Fund Management, Massar Capital Management, Duet Group, Oracle Corporation (ORCL), Gitlab Inc (GTLB), and More
Billionaire Investor Carl Icahn Warns a Market Crisis is Brewing, Says Bitcoin may be an Inflation Hedge, and Reflects on His Apple and Netflix Bets in a New Interview. Here are the 7 Best Quotes.
Hedge Fund and Insider Trading News: Chase Coleman, Jim Simons, Luxury Capital Group, Jana Partners, Zoom Video Communications (ZM), DLP Resources Inc (DLPRF), and More
The past year and a half has been GREAT for hedge fund managers. After taking a temporary beating in the early days of the beginning of pandemic, hedge fund managers have bounced back in a big way.
Billionaire Hedge Funds
